1. Acknowledgement to Referees

   Acknowledgement to Referees 15 November 2017 Pages: 421 - 423

2. Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions

   • Gail M. Annich
   • Oshri Zaulan
   • Melissa M. Reynolds

   Review Article 23 May 2017 Pages: 425 - 439

   

3. Nuclear Cardiology: Are We Using the Right Protocols and Tracers the Right Way?

   • Maurizio Dondi
   • Thomas Pascual
   • Andrew J. Einstein

   Review Article 25 April 2017 Pages: 441 - 446

4. Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs

   • Julie Butters
   • Alex Brown
   • Stephen J. Nicholls

   Review Article 21 April 2017 Pages: 447 - 452

5. Effects of Levosimendan on Patients with Heart Failure Complicating Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials

   • Guokai Shang
   • Xinyan Yang
   • Ming Zhong

   Systematic Review 08 June 2017 Pages: 453 - 463

   

6. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States

   • Raymond G. Schlienger
   • Jonathan R. Korn
   • Jason Yeaw

   Original Research Article 04 August 2017 Pages: 465 - 474

   

7. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols

   • Evan Draper
   • Brandon Parkhurst
   • Sara Griesbach

   Original Research Article 08 September 2017 Pages: 475 - 479

8. All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin

   • Adrienne M. Gilligan
   • Pranav Gandhi
   • David M. Smith

   Original Research Article Open access 09 August 2017 Pages: 481 - 492

9. Comment on: “Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs”

   • Martin A. Urtasun
   • Guillermo R. Prozzi
   • Perla Mordujovich

   Letter to the Editor 18 May 2017 Pages: 493 - 495

10. Authors’ Reply to Urtasun et al.: “Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs”

    • Dixon Thomas
    • Seeba Zachariah
    • Jason C. Cooper

    Letter to the Editor 18 May 2017 Pages: 497 - 498